Ph1-negative chronic myeloproliferative neoplasms (MPN), immune thrombocytopenic purpura (ITP), and thrombotic thrombocytopenic purpura (PTT)
Clinical and laboratory research group, dedicated to the study and treatment of Ph1-negative chronic myeloproliferative neoplasms (MPN): myelofibrosis, polycythemia vera, and essential thrombocythemia; immune thrombocytopenic purpura (ITP); and Thrombotic Thrombocytopenic Purpura (PTT).The group’s research objective is to provide clinical assistence at the highest level, guaranteeing the many patients with MPN, ITP, or PTT the best therapies that the international scientific community can provide.
Areas:
Oncology and Haematology